DANIEL WESEMANN: Open Payments
NPI 1366435125 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 5 payments from 2 companies in 2025. Trend: 2023 $304 · 2024 $8,450 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $194 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
Products named: INGREZZA, COBENFY.
Industry payments across IA — which companies pay providers there.
